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Abstract. The high concentration of glycosphingolipids 
on the apical surface of epithelial cells may be gener- 
ated by selective transport from their site of synthesis 
to the cell surface. Previously, we showed that canine 
kidney MDCK and human intestinal Caco-2 cells con- 
vetted a ceramide carrying the short fluorescent fatty 
acid Cr-NBD to glucosylceramide (GlcCer) and sphin- 
gomyelin (SM), and that GlcCer was preferentially 
transported to the apical surface as compared to SM. 
Here, we address the point that not all glycosphin- 
golipid classes are apically enriched in epithelia. We 
show that a ceramide containing the 2-hydroxy fatty 
acid C60H  was preferentially converted by MDCK and 
Caco-2 cells to galactosylceramide (GalCer) and its de- 
rivatives galabiosylceramide (Ga2Cer) and sulfatide 
(SGalCer) as compared to SM and GlcCer--all endog- 
enous lipid classes of these cells. Transport to the apical 
and basolateral cell surface was monitored by a BSA- 
depletion assay. In MDCK cells, GalCer reached the 
cell surface with a two- to sixfold lower apical/basolat- 
eral polarity than GlcCer. Remarkably, in Caco-2 cells 
GalCer and GlcCer displayed the same apical/basolat- 
eral polarity, but it was sixfold lower for lipids with a 
CrOH chain than for C6-NBD  lipids. Therefore, the 
sorting of a sphingolipid appears to depend on lipid 
structure and cell type. We propose that the different 
ratios of gluco- and galactosphingolipid synthesis in the 
various epithelial tissues govern lipid sorting in the 
membrane of the trans Golgi network by dictating the 
composition of the domains from where vesicles bud to 
the apical and basolateral cell surface. 
LYCOSPHINGOLIPIDS form  a  highly  polymorphic 
class of lipids. In mammalian cells they occur in a 
number of cellular  membranes but are mainly ex- 
pressed on the cell surface, where they are thought to play 
a role in cell signaling  and recognition (17). The carbohy- 
drate structures in most glycolipid series are based on the 
(Gal [M-4 Glc 131-) of lactosylceramide. Glucosylceramide 
(GlcCer) 1 therefore is the precursor for most glycolipid 
species.  GlcCer itself has been implicated in growth and 
development (42). The other major monohexosylceramide, 
GalCer, serves as a precursor for only a few simple glycolip- 
ids, sulfatide (SGalCer), galabiosylceramide (GaECer), and 
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the ganglioside  sialo-galactosylceramide  (I3NeuAc-GalCer, 
or "GM4"  ). 
While  glycosphingolipids  constitute  only  a  few mole 
percent of the lipids  in most membranes, they are major 
components of the apical plasma membrane of a number 
of epithelial cells in the gastrointestinal and urinary tracts 
and of myelin (reviewed in 33, 45, 47). In intestinal cells 
glycosphingolipids make up one third of the lipids in the 
apical  membrane  while  the  other  two thirds  consist  of 
phospholipids  and cholesterol. If restricted to the outer 
leaflet, the glycosphingolipids essentially cover the apical 
surface. The basolateral plasma membrane  domain con- 
tains lower levels of glycosphingolipids and is enriched in 
the phospholipid PC and the (sphingo)phospholipid sphin- 
gomyelin (SM; 47). 
Differences in the apical/basolateral polarity of the vari- 
ous lipids have also been documented for epithelial cells in 
culture. The distribution of the phospholipids PC and PE 
in MDCK cells was very similar to that found in intestinal 
tissue (see reference 47). To study the cellular processes 
responsible for these differences, we have developed an 
assay for transport of newly synthesized lipids to the two 
plasma membrane  domains  of epithelial  cells  in culture 
(53, 55, 56). Newly synthesized short-chain GlcCer was de- 
livered preferentially to the apical surface in MDCK cells 
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was not. The difference in polarity of delivery between 
GlcCer and SM in Caco-2 cells was sufficient to generate 
the apical enrichment of GlcCer over SM that has been 
observed in intestinal ceils in vivo. Based on this observa- 
tion, a model was formulated where glycosphingolipids ag- 
gregate into domains in the lumenal leaflet of the mem- 
brane of the TGN analogous to the sorting of membrane 
proteins  (47).  These lipid domains, which are  presently 
also supposed to be enriched in proteins anchored to the 
membrane by a glycolipid tail (reviewed in reference 15), 
would then be transported by vesicles to the apical surface 
by an as yet unknown mechanism. 
Although all present evidence supports the idea of lipid 
domains, lipid sorting in epithelia must involve more than 
the lateral segregation of apical GlcCer from basolateral 
SM and PC in the TGN because: (a) In human intestinal 
and kidney epithelial cells GalCer and not GlcCer is by far 
the major monohexosyl ceramide, while 40--60% of the to- 
tal glycolipids are complex glycolipids notably SGalCer (7, 
11, 46). In dog kidney (113) and dog kidney--derived MDCK 
cells (20, 37) the monohexosylceramide (40-60%  of total 
glycolipid) contains some 20%  GalCer. (b) Although the 
glycosphingolipids  in MDCK ceils  overall contain a  cera- 
mide backbone composed of sphingosine (4-sphingenine) 
and nonhydroxy fatty acids (NFA; 20, 37), glycolipids in 
intestinal cells of rat and man mainly possess ceramides 
consisting  of  phytosphingosine  (4-hydroxysphinganine) 
and 2-hydroxy fatty acids (HFA; 5, 11, 13, 19, 35). These 
additional hydroxyl groups in the ceramide moiety may 
well facilitate intermolecular hydrogen bonding between 
glycolipids (3).  (c) In contrast to GlcCer, some complex 
glycosphingolipids were not found to be enriched on the 
apical surface in intestinal epithelial cells (13, 18, 24). This 
was  also  found for  kidney cells  (48),  and  the  GalCer/ 
GlcCer ratio was twofold lower on the apical than on the 
basolateral surface of MDCK (36).  (d) Preferential trans- 
port of GlcCer over SM to the basolateral cell surface was 
observed in Fischer rat thyroid cells (60). 
In the present study we extend our previous work on the 
intracellular transport and sorting of SM and GlcCer to 
galactose-containing glycosphingolipids. In colon ceils, the 
polarity of these lipids is of relevance for medicine: Gal- 
Cer and SGalCer have attracted attention as potential re- 
ceptors for HIV (41, 58), while Ga2Cer, like globotriosyl- 
ceramide, plays a deleterious role as a receptor for Shiga 
toxin and verotoxin (9, 28). Our results show that the vari- 
ous glycosphingolipids are delivered to the epithelial cell 
surface with different apical/basolateral polarities. The ob- 
served differences, that depend on the structure of both 
the carbohydrate headgroup and the ceramide backbone, 
fit well with polarity data in the literature. The results re- 
fine the model of epithelial lipid sorting where apical and 
basolateral lipids are segregated by domain formation in 
the Golgi and provide insight into cellular trafficking of 
galactolipids. 
Materials and Methods 
Cells 
MDCK cells, clones strain I  (14) and strain II (30),  were originally ob- 
tained from K. Simons (EMBL, Heidelberg, Germany). They were pas- 
saged and grown as 3- or 4-d-old monolayers on filters glued to the bottom 
of plastic rings (Transwell; Costar Corp., Cambridge, MA) as described 
before (54, 55). Caco-2 cells, clone PD7, were passaged as described (8) 
and used on day 7-15 in culture (56; but on Transwell filters in 10% FCS). 
Chemical Synthesis of Radiolabeled Ceramides 
D-Erythro-[4,5JH]-Sphinganine.  Synthesis was modified from the method 
of G. Brenner-Weiss (personal communication). An excess of 25 mg of 
D-erythro-sphingosine was dissolved in 2.5 ml methanol/water (4:1, vol/ 
vol) in a screw-capped vial. After addition of 50 ixl palladium acetate (50 
mM in tetrahydrnfuran) and 33  p~l acetic acid, the mixture was flushed 
with N2 and frozen in liquid N2. 200 ixl methanol/water (4:1, vol/vol) was 
added and frozen as a second layer on top. 2.3 ixmol NaB[3H]4 (925 MBq) 
in 1 ml 0.4 M NaOH was added to the frozen mixture. The vial was flushed 
with N2, closed, and thawed at room temperature under stirring. After 
16 h the reaction mixture was centrifuged at 2,000 rpm for 5 rain and the 
supernatant was concentrated in the rotary evaporator under addition of 
methanol/water and chloroform to remove excess tritium. Lipids were col- 
lected in the lower phase of a two-phase extraction (2), dried under N2, 
and dissolved in chloroform/methanol (1:2, vol/vol). 
D-erythro-[4,5-3H]sphinganine was purified twice by thin layer chro- 
matography (TLC) on silica 60 TLC-plates (20 ×  20 cm  2) in chloroform/ 
methanol/2 M NI-I4OH (40:10:1, vol/vol). Products were detected with a 
[3-camera (Birchover Instruments, Letchworth Herts, England) and iden- 
tified by comigration with nonradioactive standards (R~phins~ine =  0.40, 
Rfspmgam  e =  0.28, visualized with 0.2% ninhydrin in ethanol). Sphinga- 
nine was extracted from the silica with chloroform/methanol (1:1, vol/vol) 
and chloroform/methanol/water (1:2.2:1, vol/vol). The lower phase of the 
Bligh and Dyer extraction (2) was dried under N2 and dissolved in chloro- 
form/methanol (1:2, vol/vol). Purity was checked by TLC (see above) and 
fluorography.  The  yield  of  the  tritiation  was  54  MBq  D-erythro- 
[4,5-3H]sphinganine with a calculated specific activity of 201 MBq/p,  mol. 
Radiolabeled Cemmides. In  a  modification of an  established method 
(39), 14C-labeled hexanoic acid (0.58 mg; 0.15 MBq/ixmol), unlabeled hex- 
anoic acid (0.58 mg), or (D,L-2-hydroxy)hexanoic acid (0.2 rag) were dis- 
solved in dry ethylacetate (0.5 ml). Equimolar quantities of N-hydroxysuc- 
cinimide and dicyclohexylcarbodiimide were added and allowed to react 
overnight at room temperature in the dark. Thereafter, 1 ml of ethylace- 
tate was added and the samples were centrifuged for 5 rain at 2,000 rpm. 
The supernatant was dried under N2, dissolved in freshly distilled tetrahy- 
drofuran  and  added  to  D-erythro-sphingosine  (1.5  rag),  D-erythro- 
[3-3H]sphingosine (1.3 MBq; 814 MBq/~mol) or D-erythro-[4,5-3H]sphin  - 
ganine (23 MBq; 201 MBq/l~mol) in tetrahydrofuran to a final volume of 
0.3 ml. After an overnight incubation at room temperature in the dark the 
samples were dried under Nz. The ceramide products were purified twice 
by preparative TLC in chloroform/methanol/acetic acid (90:2:8, vol/vol) 
for NFA-ceramides, or chloroform/methanol/25%NH4OH (190:15:1, vol/ 
vol) for HFA-ceramides. The products were detected with a 13-camera. A 
minor part of the sample was run in a parallel lane and detected by spray- 
ing with 0.1% rhodamine 6G in methanol. Ceramides were scraped from 
the plate and extracted from the silica (2). The upper phase was washed 
once with chloroform. The lower phases were dried under N2 and dis- 
solved in chloroform/methanol (2:1).  The D- and L-stereoisomers of the 
HFA-ceramides were separated by TLC in chloroform/methanol/acetic 
acid (90:2:8, vol/vol), followed by a run in diethylether. For products and 
specific activities, see Fig. 1 and Table I. 
Lipid Analysis 
Lipids were extracted from cells and media by a two-phase extraction (2). 
The upper phase contained 20 mM acetic acid and (for radiolabeled lip- 
ids) 120 mM KCI. After a chloroform wash, which was added to the lower 
phase, lipids remaining in the upper phase (SGalCer) were collected on 
SepPak C18 cartridges (Waters, Milford, MA), from which lipids were 
eluted with chloroform/methanol/water (1:2.2:0.1) and methanol. The or- 
ganic (lower) phase was dried under N 2 and the lipids were applied to 
TLC plates, that had been dipped in 2.5% boric acid in methanol (25), 
dried, and activated by heating at ll0°C for 30 rain. They were developed 
in two dimensions: I. chloroform/methanol/25%NI-LOH/water (65:35:4:4, 
vol/vol), and II. chloroform/acetone/methanol/acetic  acid/water (50:20:10: 
10:5, vol/vol). 
Fluorescent spots were detected under  UV, scraped from the TLC 
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Figure 1.  Chemical structure (38) of fluorescent and radiolabeled 
short-chain ceramides. (1) Cer(C6-NBD),  (2) C.er(C6OH-NBD), 
(3) [3H]dh-Cer(C6), (4) [3H]dh-Cer(C6OH),  (5) Cer([14C]C6), (6) 
[3H]Cer(C6OH).  1, 2, 5,  and  6  contain  sphingosine (4-sphinge- 
nine), while 3  and 4 contain dihydrosphingosine (sphinganine) as 
the sphingoid base. (R) -H in 1, 3, and 5; -OH in 2, 4, and 6; the 
natural  (D-2OH)  and  unnatural  (L-2OH)  stereoisomers  were 
studied separately. (*) [3H] in 3, 4, and 6; (lq) [14C] in 5. 
plates, and the fluorescent lipid analogs were extracted from the silica in 2 
mi chloroform/methanol/20 mM acetic acid (1:2.2:1,  vol/vol) for 30 min. 
After pelleting the silica for 10 min at 1,500 rpm, fluorescence in the su- 
pematant was quantified in a fluorimeter (Kontron, Zilrich, Switzerland). 
Radiolabeled spots were detected by fluorography after dipping the TLC 
plates in 0.4%  PPO  in 2-methylnaphthalene with 10%  xylene (4). Pre- 
flashed film (Kodak X-Omat S, France) was exposed to the TLC plates 
for 3 d at -80°C. The radioactive spots were scraped from the plates and 
the radioactivity was quantified by liquid scintillation counting in 0.3 ml 
Solulyte (J.T. Baker Chemicals, Deventer, The Netherlands) and 3 ml of 
Ultima Gold (Packard Instruments, Downers Grove, IL). 
Enzymatic Degradation of Galactolipids 
with Galactosidases 
Lipids were mixed with 250  p~g Na-taurocholate (in 50  p~! chloroform/ 
methanol, 2:1, vol/vol) and the solvent was evaporated. The samples were 
dissolved in 450 p~l of 84 mM Na2HPO4, 58 mM citric acid, and 2  mM 
EDTA (pH 4.2), 0.15 U of a- or ~-galactosidase was added (75 p~l) and the 
mixture was incubated for 24 h at 37°C. Lipids were extracted and identi- 
fied by TLC, by comparison with standards on borate-treated plates in 
solvent I (see above). 
Transport Incubations 
Transport of lipids to the epithelial cell surface was measured essentially 
as before (53, 56). In short, BSA complexes of the ceramides were pre- 
pared by injection of 10 p~l of an ethanolic solution of the ceramides into 
Hanks' balanced salt solution without bicarbonate, 10 mM Hepes, pH 7.4 
(HBSS'), containing 1% (wt/vol) BSA (HBSS' +  BSA). Cell monolayers 
on filters were washed three times with HBSS' and placed in a six-well 
cluster dish. Each well contained 2 ml of a ceramide suspension in HBSS' 
+  BSA and 1 ml was applied to the apical side. Cells were incubated at 
37°C for 1 or 2 h, during which period short-chain lipids reaching the cell 
surface should be depleted into the medium by the BSA. After collection 
of the apical and basolateral medium, remaining short-chain lipids were 
washed from the cell surface in HBSS' + BSA for 30 rain at 10°C, at which 
temperature  sphingolipid  transport  to  the  cell  surface  is  essentially 
blocked (56). The apical and basolateral washes were pooled with the cor- 
responding 37°C media and the filter was cut from its ring, after which the 
lipids in media and cells were analyzed. For C6-NBD analyses media and 
cells from two filters were combined. 
To assess what part of the sphingolipids was synthesized on the cell sur- 
face, cells were incubated with 60 nM [3H]dh-Cer(C6OH) at 10°C with 
BSA present in the HBSS' on both sides to extract products from the cell 
surface (52). After a 3.5 h incubation the cells were washed with HBSS' + 
BSA for 30 min at 10°C, and the 3H-lipids in the media and the cells were 
analyzed. 
Calculation of Transport and Polarity 
The transport of a short-chain lipid to the cell surface was expressed as the 
percentage of the total amount of that lipid in cells and media that was re- 
covered in the BSA media. The apical/basolateral polarity of the delivery 
Table I. Biosynthesis of  Sphingolipids  from Various Precursor Ceramides* 
Total incorporation 
Cells  Ceramide  SM  GlcCer  GalCer  Ga2Cer  SGalCer  (percent of added precursor) 
(percent of total) 
MDCK I  NFA  Cer(C6-NBD)  ~1  79  20  2 
HFA  [3H]dh-Cer(C6[D-2OH])  48  20  32  6 
MDCK II  NFA  Cer(C6-NBD  )  86  14  0.5  1 
Cer([t4C]C6)  84  16  2 
[3H]dh-Cer(C6)  100  4 
HFA  Cer(C6[D-2OH]-NBD) §  28  72  2 
Cer(C~[L-2OH]-NBD)  §  100  ,,  1 
[3H]Cer(C6[D-2OH])  15  5  52  16  12  7- 
[3H]dh-Cer(C6[D-2OH])  9  4  54  17  16  6  '  ,~ 
[3H]dh-Cer(C6[L-2OH])§  100  4 
Caco-2  NFA  Cer(C6-NBD)I  51  48  0.3  4 
Cer([14C]C6)  90  10  6 
[3H]dh-Cer(C6)  83  17  2 
HFA  [3H]Cer(C6[D-2OH])  13  20  48  16  7 
[3H]dh-Cer(C6[D-2OH])  17  9  56  18  7 
[3H]dh-Cer(C6[L-2OH])  100  10 
*Cells on filters were incubated for 1 h at 37°C in the presence of Cer(Cs-NBD) (5 p~M), Cer([14C]C6) (0.15 MBq/p~mol; 15 p~M), [3H]ceramides (814 MBq/p.mol; 15 nM) or 
[3H]dh-ceramides (201 MBq/ixmol; 60 nM) in both apical and basolateral medium. After the incubation fipids were extracted from the cells and the combined incubation media, 
and analyzed as described under Materials and Methods. In each case the data from a typical experiment are presented as percent of  total labeled sphingolipid. 100%: no other spot 
identified. 
~25 p~M. 
¢Ceramide  was added to the apical surface only. 
ITraces (< 1% of total) of two other lipids (L and (3) were detected in Caco-2 (L) and MDCK I cells (L and G). They were identified by ct- and [3-galactosidase  treatments as L: 
lactosylceramide (Ga161-4 GlcCer) and G: globotriosylceramide (Gal al--4 Gall~l-4 GlcCer). 
van der Bijl et al. Epithelial Glycolipid Sorting  815 Figure2 TLC autoradiograms of  products from [3H]dh-Cer(C6OH) 
in MDCK II cells. (A) Cells were incubated for 1 h at 37°C (cf. 
Table I). Lipids were separated on 2D-TLC on borate-treated 
plates and visualized. O, origin. (B) GalCer was hydrolyzed by 
13-galactosidase (/3) but not a-galactosidase  (a) to ceramide. (C) 
Ga2Cer was hydrolyzed by et-galactosidase (a) but not 13-galac- 
tosidase (13) to GalCer. During a second hydrolysis again about 
half of the remaining Ga2Cer was hydrolyzed (not shown). (D) 
[35S]Sulfation of MDCK II cells (0.74 MBq, 20 pmol in 1 ml per 
dish, 6 h at 37°C) gave two spots, which by colocalization were 
identified as SGalCer (1) and sulfated lactosylceramide (2). (E) 
Addition of unlabeled  dh-Cer(C6OH) during  [35S]sulfation gave 
rise to a third 35S-spot (3) which was also labeled with [3H]dh- 
Cer(C6OH) in A: SGalCer(C6OH ). 
of a lipid was defined as the ratio of the amount recovered in the apical 
medium over that in basal medium. The relative polarity is the quotient of 
the polarities of two lipids, and is taken as a measure for lipid sorting (see 
reference 56). 
Materials 
D-erythro-sphingosine,  D,L-dihydrosphingosine,  hexanoic  acid,  (D,L-2- 
hydroxy)hexanoic  acid,  [1-14C]hexanoic  acid,  ct-  and  [3-galactosidases 
(from Aspergillus niger and jack beans, respectively), and BSA fraction V 
were purchased from Sigma Chemical Co. (St. Louis, MO). NaB[3H]4 and 
D-erythro-[3-3H]-sphingosine  were  from  Du  Pont  (Wilmington,  DE). 
[35S]Sulfate  was  obtained  from  Amersham  Corp.  (Amersham,  UK). 
Cer(C6-NBD)  was  from  Molecular  Probes  (Eugene,  OR).  Cer(C6[D- 
2OH]-NBD),  and Cer(C6[L-2OH]-NBD)  were kindly donated by R. Pa- 
gano (Rochester, MN). SM(C6-NBD), GIcCer(C6-NBD), and GalCer(C6- 
NBD) were synthesized as before (53). (C6-NBD)lactosylceramide was a 
gift from J.W.  Kok  (University of Groningen,  Groningen, The Nether- 
lands), and SGalCer(C12-NBD)  was synthesized by S.  Marchesini (Uni- 
versity of Brescia, Brescia, Italy). 
Results 
MDCK and Caco-2 Cells 
Preferentially Use HFA-Ceramides for the Synthesis 
of Galactosphingolipids 
The precursor ceramides used in the present study con- 
tained a C6 fatty acid (Fig. 1). Because of this short-chain 
the ceramides can exchange between membranes  across 
an aqueous phase, and the absence of a polar headgroup 
allows  translocation  across  cellular  membranes.  When 
added to MDCK and Caco-2 cells, the ceramides entered 
the cells and reached the SM synthase and various glyco- 
syltransferases  as  evidenced  by  the  variety of products 
formed (Table I, Fig. 2 A). Clearly, the presence of 1% 
BSA, which was added to deplete short-chain lipid prod- 
ucts from the cell surface (see below), did not prevent ce- 
ramide incorporation. 
All ceramides were converted to SM (Table I). The var- 
ious SM's were identified by comigration with a  SM(C6- 
NBD) standard in two-dimensional TLC, and by sensitiv- 
ity to bacterial sphingomyelinase (not shown). Significant 
amounts of GlcCer were formed from Cer(C6-NBD) (53, 
56) and from the other ceramides containing an NFA, ex- 
cept from dh-Cer(C6) in MDCK II as had been reported 
for dh-Cer(C6-NBD) (55). GlcCer, as identified by comi- 
gration with a  standard and by the fact that its synthesis 
was inhibited by the specific inhibitor of ceramide gluco- 
syltransferase PDMP (10 ~M for 1.5 h at 37°C; results not 
shown; 42), was also synthesized from the natural D-form 
of the HFA ceramides. As for the NBD-lipid (40), virtu- 
ally no glycolipid synthesis from the L-forms was detected. 
In  striking  contrast  with  the  NFA-ceramides,  which 
were preferentially glucosylated, the ceramides containing 
a D-2OH fatty acid gave rise to a main product that comi- 
grated  with  a  GalCer(C6-NBD)  standard.  This  product 
from [3H]dh-Cer(C6OH) in MDCK II cells was identified 
as GalCer as it could be hydrolyzed to ceramide by 13-galac- 
tosidase (Fig. 2 B). A  second new 3H-spot on TLC comi- 
grated  with  (C6-NBD)lactosylceramide.  Degradation  by 
ot-galactosidase,  and  not  by  13-galactosidase,  to  GalCer 
(Fig. 2 C) identified this product as Ga2Cer (Gal od-4 Gal- 
Cer), an endogenous lipid in MDCK II (37). A  third new 
[3H]C6OH product on the TLC plate (Fig. 2 A) migrated 
close to SGalCer(Cm-NBD). Additional support of it be- 
ing SGalCer was: (a) its retention on a DEAE-Sephadex 
column (27); (b) inhibition of its synthesis (to ~  15%) by 
50 mM sodium chlorate after an  18 h  chlorate pretreat- 
ment (1); (c) its labeling with [35S]sulfate, when unlabeled 
Cer(C6OH) was added to the incubation (Fig. 2, D and E); 
(d) lack of inhibition of its synthesis by the glucosyltrans- 
ferase inhibitor PDMP (42), corroborating its identity as 
SGalCer (sulfatide, HSO3-3GalCer) and not sulfated lac- 
tosylceramide. 
As in MDCK II cells, in Caco-2 cells HFA-ceramides 
were  preferentially converted  to  GalCer  and  SGalCer. 
Ga2Cer was not observed. The synthesis of five different 
lipids from one precursor ceramide provided the opportu- 
nity to compare transport and sorting of these lipids inde- 
pendent of ceramide backbone, while the synthesis of the 
same lipid class from different ceramides created the pos- 
sibility to study the dependence of transport and sorting 
on the lipid backbone. 
Transport of  Newly Synthesized Lipids to the 
Cell Surface 
Synthesis of GalCer, GlcCer, and  SM on the surface of 
Caco-2 cells, as assayed at 10°C (Materials and Methods), 
was negligible as was transport to the cell surface at 10°C. 
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Polarity of delivery (apical/basolateral)  Relative polarity 
Ceramide  SM  GlcCer  GalCer  GIcCer/SM  GlcCer/GalCer 
NFA Cer(Ct-NBD)  0.6 ±  0.1 (16)  1.2 ___ 0.2 (16)  2.0 +- 0.4 (16) 
HFA [3H]dh-Cer(CtOH)  0.2 +-- 0.0 (6)  0.7 +-- 0.2 (6)  0.1  +  0.0 (6)  2.7 ±  0.7 (6)  5.5 -  1.4 (6) 
The presence of ceramide at 37°C increased the signal in the sphingolipids. As synthesis occurred during the transport incubation, transport as percent in the medium after the 
37°C incubation was somewhat lower than in previous experiments in which eeramide was added at 10°C and removed before warming to 37°C (53, 56). The fraction of SM, 
GlcCer, and GalCer extracted into the medium during the 1 h at 37°C (and the 10°C BSA-wash) was 50--60% vs. 60-70% in the earlier studies on MDCK and 40-50% vs. 50-60% 
for Caco-2. Delivery of the higher glycosphingolipids  SGalCer(CtOH) and Ga2Cer(CtOH)  lagged behind delivery of GlcCer and GalCer, with 30-40% in the medium after 1 h at 
37°C. 
*Cell monolayers on filters were incubated with ceramide analogs in the concentrations mentioned in Table I at 37°C for 1 or 2 h (without differences),  and the polarity of delivery 
to the cell surface was measured as described under Materials and Methods.  Data are presented as mean-+SD (number of samples). Relative polarity was calculated for each indi- 
vidual experiment. 
Over  97%  of  each  product  of  [3H]dh-Cer(C6OH)  was 
found in the cells after 3.5 h at 10°C. However, 20 +  1% 
(n  =  4) of newly synthesized [3H]dh-SM(C6OH) was re- 
covered in the basolateral HBSS'  +  BSA  of MDCK II 
cells.  This is  in  line  with  earlier findings  using  Cer(C6- 
NBD) and has been interpreted as reflecting the presence 
of a SM synthase on the basolateral surface of MDCK II 
cells. The relative contribution of this enzyme to the total 
SM synthesis is thought to be of minor importance at 37°C 
as it was found to decrease at higher temperature (52). 
After the cells had been incubated with short-chain ce- 
ramides at 37°C in the presence of BSA, up to 60% of the 
various sphingolipid products were found in the medium, 
reflecting transport from their site of synthesis to the cell 
surface and extraction from the apical and basolateral sur- 
face by the BSA. The depletion rates by BSA were the 
same for SM, GlcCer, GalCer, and Ga2Cer. This was es- 
tablished in an experiment, where MDCK II cells synthe- 
sized these lipids from [3H]dh-Cer(C6OH) at 37°C in the 
absence of BSA, after which  ~H]C60H lipids were de- 
pleted from the apical cell surface by BSA in two 30 min 
incubations  at  10°C.  For  each  3H-lipid  88%  of the  ex- 
changeable amount of that lipid on the apical surface was 
depleted in the first incubation, and 12% in the second. 
Newly Synthesized GalCer Is Enriched over GlcCer on 
the Basolateral Surface of MDCK Cells 
The apical/basolateral polarities with which  GlcCer and 
SM reached the surface of the two plasma membrane do- 
mains of MDCK cells are similar to those reported previ- 
ously for the C6-NBD lipids (53--55), although the experi- 
mental protocol was slightly different (Tables II and III). 
In both MDCK I  and II the relative polarity GlcCer/SM 
was 2.0 for the Ct-NBD lipids. Similarly, it was 2.2 for the 
[14C]C6 chain in MDCK II. Although the absolute polarity 
of delivery of SM and GlcCer tended to be lower for the 
HFA-lipids than for the NFA-lipids, the relative polarity 
GlcCer/SM was similar for C6-OH and C6. 
Interestingly, GalCer did not reach the MDCK cell sur- 
face with the same apical/basolateral polarity as GlcCer: It 
was delivered more basolaterally than GlcCer especially in 
MDCK I (sixfold) but also in MDCK II. In initial experi- 
ments on MDCK II using Cer(C6[D-2OH]-NBD), fluores- 
cent GalCer was more basolateral than SM. In subsequent 
experiments, the relative polarity GlcCer/GalCer was 2.8 
for the C6-NBD analogs, 2.0 for the CtOH analogs, and 1.4 
for  the  dihydro-C60H  species.  The  GalCer  derivatives 
SGalCer and Ga2Cer were delivered to the MDCK II cell 
surface with a polarity very similar to that of GalCer itself 
(Table III). 
Newly Synthesized GalCer Behaves Like GlcCer in 
Caco-2 Cells 
In the Caco-2 clone PD7 the relative polarity GlcCer/SM 
for both the C6-NBD and the [14C]C  6 chain of 12.7 (Table 
IV) was much higher than in MDCK (Table II and III) 
and about two times higher than the values reported for 
the parent Caco-2 line (55, 56). A difference in the polarity 
of GlcCer and SM of about 2 was observed for the C60H 
species.  In contrast to the  situation  in  MDCK cells, no 
sorting  between  GlcCer  and  GalCer  was  observed  in 
Caco-2 as reflected by the value of 1 for the relative polar- 
ity  GlcCer/GalCer  for  the  C6-NBD,  C60H,  and  the 
dihydroC60H  analogs  (Table IV).  However,  in  Caco-2 
cells the presence of the C60H chain caused a drastic shift 
of both glycolipids but not of SM to the basolateral sur- 
Table III. Polarity of  Surface Delivery of  Newly Synthesized Sphingolipids in MDCK H Cells* 
Polarity of delivery (apical/basolateral)  Relative polarity 
Ceramide  SM  GlcCer  GalCer  SGalCer  Ga2Cer  GIcCer/SM  GlcCer/GalCer 
NFA Cer(Ct-NBD)*~  0.8 ±  0.1 (12)  1.5 ±  0.3 (12)  0.6 --- 0.3 (8)  2.0 ±  0.5 (12)  2.8 ±  1.3 (8) 
Cer([14C]C6)  0.6 -  0.1 (4)  1.2 --- 0.1 (4)  2.2 -+ 0.4 (4) 
I-IFA [3H]Cer(C6-OH)  0.4 ±  0.1 (4)  1.4 ±  0.2 (4)  0.7 --- 0.1 (4)  0.5 -+ 0.2 (4)  0.6 -  0.1 (4)  3.7 -+  1.1 (4)  2.0 --- 0.2 (4) 
[3H]dh-Cer(Ct-OH)  0.4 ±  0.1 (14)  1.0 ±  0.3 (13)  0.7 ±  0.1 (14)  0.6 -  0.2 (5)  0.5 +  0.1 (14)  2.6 --- 0.4 (13)  1.4 -+ 0.2 (13) 
*See the legend to Table II, but all incubations 1 h 37°C. 
~5, 10, and 15 p.M. 
~he side of ceramide addition has been repor~d to influence the resulting apical/basolateral  polarity of the products (54). Indeed the absolute polarity of delivery  of SM(Ct-NBD) 
and GIcCer(Ct-NBD  ) was intermediate between the absolute polarities found after apical addition, 0.8 and 1.7, and after basolateral addition alone, 0.6 and 1.2 (54). Still, the dif- 
ference in polarity between SM(Ct-NBD ) and GlcCer(Ct-NBD  ) as expressed by the relative polarity GlcCer/SM was 2 in all cases. 
van der Bijl et al. Epithelial Glycolipid Sorting  817 Table IV. Polarity of Surface Delivery of  Newly Synthesized Sphingolipids in Caco-2 Cells* 
Polarity of delivery (apical/basolateral) 
Ceramide  SM  GlcCer  GalCer  SGalCer 
Relative polarity 
GIcCer/SM  GleCer/GalCer 
NFA Cer(C6-NBD)  0.3 +  0.1 (13)  2.7 -+ 1. I (13)  2.4 +  1.0 (7)  12.7 --- 7.7 (13)  1.1  --- 0.4 (7) 
Cer([14C]C6)  0.2 ±  0.1 (11)  1.6 ±  0.6 (11)  12.7  ±  7.1 (11) 
HFA [3H]Cer(C6OH)  0.2 ±  0.0 (8)  0.4 --- 0.1 (8)  0.4 +  0.1 (8)  0.3 ___ 0.2 (4)  2.0 --- 0.6 (8)  1.0 ±  0.2 (8) 
[3H]dh-Cer(C6OH)  0.2 ±  0.1 (17)  0.4 ±  0.1 (12)  0.4 -  0.1 (15)  0.1  ±  0.1 (7)  2.4 ±  1.1 (12)  1.1  ±  0.3 (12) 
*See the legend to Table II, 
face. Finally, SGalCer produced after incubation of the 
cells with [3H]dh-Cer(C6OH) was fourfold more basolat- 
eral than the corresponding GalCer. 
Two  types  of experiments  were  performed  to  assess 
whether the short-chain analogs behaved as probes or in- 
fluenced the  system  under  study.  First,  [3H]Cer(C6OH) 
was added to MDCK II and Caco-2 cells in the presence of 
a  100-fold  higher  concentration  (5  p~M) of  unlabeled 
Cer(C6OH).  No  effects  were  observed  on  the  relative 
amount of synthesis of the various 3H-lipids and on the po- 
larity of delivery of these lipids to the cell surface (data not 
shown). When the concentration of (C6-NBD)Cer was in- 
creased from 5-25 IxM, a slight reduction of 10--20%  was 
observed in transport of SM and GlcCer to the surface of 
MDCK and  Caco-2 cells, without effect on polarities of 
delivery. Second, we investigated whether the differences in 
polarity between the various C6-NBD- and C60H sphin- 
golipids (Tables III and IV) could be measured simulta- 
neously in the same cells. For this, MDCK II or Caco-2 
cells were incubated with a mixture of 5 ~M Cer(C6-NBD) 
and 60 nM [3H]dh-Cer(C6OH) and synthesis and transport 
to the cell surface was analyzed for the NBD-products in 
one set of cells and for the 3H-lipids in a parallel set. The 
results of this direct comparison were identical to those in 
Tables III and IV (not shown), implying that the differ- 
ences between the  C6-NBD- and C60H lipids were not 
caused by an effect of one of the short-chain ceramides (or 
their products) on the cellular machinery responsible for 
the transport and sorting of sphingolipids to the two epi- 
thelial cell surfaces. 
Discussion 
The present paper reports the basic finding that in MDCK 
and Caco-2 cells ceramides with a hydroxy fatty acid are 
preferentially converted to galactosphingolipids. The ga- 
lactosphingolipids reached the epithelial cell surface with 
a lower apical/basolateral polarity than GlcCer in MDCK 
but not in Caco-2 cells. The data provide new insights in 
the mechanism by which the differences in lipid composi- 
tion  between the  apical  and  basolateral cell surface are 
generated. 
Glycosphingolipid Biosynthesis 
GalCer is  an abundant  lipid in MDCK II cells (20, 37). 
However, only little GalCer was synthesized from NFA- 
ceramides (Table I).  GalCer synthesis could be boosted 
dramatically by feeding the cells short-chain HFA-cera- 
mides. This is in agreement with the reported preference 
of the  myelin galactosyl-transferase for HFA-ceramides 
(34).  After  synthesis,  HFA-GalCer  was  efficiently con- 
verted to GazCer and SGalCer. These lipids are endoge- 
nous to MDCK II, but as NFA- rather than HFA-deriva- 
tives (37) suggesting a low rate of fatty acid hydroxylation 
in MDCK II as opposed to kidney in vivo (23). MDCK I 
cells possess lower GalCer levels than MDCK II (20), and 
indeed were less efficient in converting HFA-ceramide to 
GalCer (Table I). The relatively high synthesis of SM and 
GlcCer from HFA-ceramide is probably an in vitro arti- 
fact. In bovine kidney, where GalCer contains only HFA, 
exclusively NFA-SM was  found (23).  Endogenous long- 
chain HFA-ceramide is made in the ER and, in contrast to 
the short-chain HFA-ceramides used here, cannot sponta- 
neously diffuse through the aqueous phase. It will first en- 
counter  the  HFA-ceramide  galactosyltransferase  which 
has been localized to the ER (43, 44, 49) and apparently 
little reaches the Golgi where the SM synthase and gluco- 
syl-transferase are located (see  16,  21, 22).  Also Caco-2 
cells produced high levels of GalCer and  SGalCer from 
HFA-ceramide but not from NFA-ceramide (Table I). In- 
deed, a high ratio of GalCer and SGalCer to GlcCer and a 
high content of HFA has been reported for human intesti- 
nal cells (11, 35, 46). 
Topology of  Sphingolipid Synthesis and 
Mechanism of Transport 
SM (16, 21, 22), lactosylceramide (see reference 26), and 
SGalCer (50) are synthesized in the lumen of the Golgi 
and are unable to translocate across the Golgi membrane. 
Thus, after synthesis they are expected to reach the cell 
surface by vesicular transport, which has been experimen- 
tally confirmed for gangliosides  (32,  59).  It  is  less  clear 
how GlcCer and GalCer are transported to the cell sur- 
face. In fiver, the glucosyltransferase is oriented towards 
the cytosol (see 22) and the myelin galactosyl-transferase 
is localized in the ER lumen (43, 44, 49). We have con- 
firmed these topologies for MDCK cells and we have mea- 
sured in vitro that newly synthesized GlcCer and GalCer 
have access to the cytosolic side of the membrane (6, 22). 
From there they can theoretically exchange to the cytoso- 
lic leaflet of the plasma membrane but translocation to- 
wards the outer leaflet has not been demonstrated (of. 57). 
More likely, GlcCer and GalCer pass through the lumen 
of  the  Golgi  before  reaching  the  cell  surface.  Indeed, 
translocation  of  GlcCer  and  GalCer  across  the  Golgi 
membrane has been shown to occur (6, 26). In the present 
study, the synthesis of Ga2Cer and SGalCer (Tables III 
and IV) also points to translocation of GalCer across the 
Golgi membrane. Recycling of GalCer from the cell sur- 
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surface is immediately extracted by the BSA in the me- 
dium. Still, it remains to be shown that passage of GlcCer 
and GalCer through the Golgi lumen is an obligatory step 
in their transport to the cell surface. 
Selectivity in Sphingolipid  Transport 
A useful parameter to assess sorting of one lipid from an- 
other is the relative polarity, a comparison of the apical/ 
basolateral polarity with which they reach the cell surface 
(56). It is independent from the apical and basolateral sur- 
face areas (and from the nature of the intracellular trans- 
port; 51). The one common observation on the sorting of 
newly synthesized sphingolipids between MDCK (Tables 
II and III) and Caco-2 (Table IV) was that GlcCer analogs 
are found enriched over the corresponding SM in the api- 
cal domain. This is in line with previous results (53, 56). 
In both MDCK lines, HFA-GIcCer and HFA-SM were 
more basolateral than their NFA counterparts but sorting 
between them was maintained. Strikingly, HFA-GalCer 
was transported more basolaterally than GlcCer with the 
same backbone, sixfold in MDCK I and twofold in MDCK 
II. The present data are in good agreement with indepen- 
dent evidence that the GlcCer/GalCer ratio in the apical 
plasma membrane in MDCK II cells is twofold higher than 
in the basolateral membrane (36).  In MDCK II, SGalCer 
and Ga2Cer displayed polarities similar to GalCer suggest- 
ing that the galactosyl group may be an important sorting 
determinant in these cells. A  different pattern of sphin- 
golipid sorting was observed in Caco-2 cells. (a) Sorting of 
NFA-GlcCer from SM was more efficient with relative po- 
larities >12. (b) GlcCer was not sorted from GalCer, inde- 
pendent of fatty acyl chain. (c)  HFA-containing GlcCer 
and  GalCer  had  a  polarity of delivery four-  to  sixfold 
lower than the NFA-analogs. In Caco-2 cells, the fatty acyl 
chain rather than the headgroup seems the major determi- 
nant in the partitioning of GlcCer and GalCer into the api- 
cal domain. (d) SGalCer had a lower polarity than GalCer, 
which suggests a role for sulfate as an additional basolat- 
eral determinant. 
Epithelial Sorting by Domain Formation in the TGN 
If the lipids destined for the apical and basolateral cell sur- 
face pass through the lumen of the TGN, they must be 
sorted by lateral segregation into apical and basolateral 
precursor domains (15, 47, 53). In support of such a sorting 
mechanism, sphingolipids have the capability to form in- 
termolecular hydrogen bonds in contrast to the glycero- 
phospholipids  like  PC  (3).  Glyco-sphingolipids  have  a 
higher capacity for hydrogen bonding than SM,  in  line 
with the sorting of GlcCer from SM that was observed un- 
der all conditions. In addition, the orientation of the hy- 
droxyls in the carbohydrate contributes to the intra- and 
intermolecular hydrogen bonding by influencing the ori- 
entation of the sugar-headgroup (38).  The observed sort- 
ing of GlcCer from GalCer can be explained by a differ- 
ence in the aggregation properties due to the orientation 
of the  hydroxyl in  the  4  position  of the  carbohydrate, 
equatorial in GlcCer and axial in GalCer. Indeed, differ- 
ences  in miscibility with phosphatidylcholine have  been 
reported  between  GlcCer  and  GalCer  (31).  Also  addi- 
tional hydroxyls in the ceramide backbone will change in- 
tra- and intermolecular hydrogen bonding (3).  Molecules 
with  a  2-hydroxyl group  on the  fatty acid were  clearly 
sorted from NFA species, especially in Caco-2 cells (Table 
IV). An effect of additional hydroxyl moieties in the sphin- 
goid base, like in the abundant phytosphingosine, can also 
be expected. Finally, differences in the structure of the en- 
dogenous lipids between MDCK and Caco-2 cells (see In- 
troduction) may greatly influence the sorting of individual 
glycosphingolipids. At present, insufficient data are avail- 
able concerning the lipid composition of the lumenal leaf- 
let of the TGN membrane in the two cell types and con- 
cerning the phase behavior of complex lipid mixtures to 
explain the observed sphingolipid sorting. 
Proteins anchored to the membrane by a glycosylphos- 
phatidylinositol tail (GPI-proteins) are transported to the 
apical surface of MDCK and Caco-2 cells. They may col- 
lect into the putative apical precursor domain in the TGN 
by  a  direct  interaction with  the  glycosphingolipids (re- 
viewed in reference 15). As MDCK and Caco-2 ceils dis- 
play differences in lipid sorting, the two cell types may uti- 
lize different lipid mixtures to create a domain of similar 
physical characteristics. Apparently, these are recognized 
by the GPI-proteins much more efficiently than by any in- 
dividual glycosphingolipid. As yet we have no idea how a 
domain on the lumenal side of the TGN membrane is rec- 
ognized as having an apical destination. An interesting ob- 
servation is that one protein thought to be involved in epi- 
thelial sorting has been found to show homology to lectins 
(12).  Interestingly, a  lactose-binding lectin has been  re- 
ported to be secreted apically by MDCK cells (29),  but 
whether it passes through the lumen of the TGN where it 
could interact with lactosylceramide is unknown. In this 
context, it cannot be excluded that individual short-chain 
lipid molecules partition into the Golgi lumen (although 
arguments have been provided to suggest that the bulk of 
each  short-chain lipid resides  in membranes; 55)  where 
they could bind to, and be transported by, carbohydrate 
receptors. The fact that a 100-fold increase in the concen- 
tration of the short-chain lipids did not influence the po- 
larities of delivery seems to argue against an important 
role for such a one-to-one lipid-receptor interaction. 
The preferential delivery of GlcCer over SM to the api- 
cal surface has been widely interpreted as implying self- 
aggregation of (all) glycosphingolipids into an apical pre- 
cursor domain (see reference 15). The present data show 
that epithelial sphingolipid sorting is more complex. No 
single glycosphingolipid is exclusively delivered to the api- 
cal cell surface, some even have a basolateral preference. 
In  addition,  different cell  types  sort  lipids  differently. 
Much attention is focused on  elucidating the  signals in 
proteins responsible for their targeting and for their inter- 
action with components of the transport machinery. Sort- 
ing of lipids presents a different set of questions. The an- 
swers may provide original angles into problems of protein 
sorting as well. 
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